In our study, NSE and CHT evolved in the same direction, increasing after chemotherapy, a fact that can be interpreted as a chemotherapeutic induction of acute inflammatory reactions, activating anti-tumor immune responses [72]. The gene discussed is ENO2; the disease is neoplasm.